Felix Biotechnology

Felix Biotechnology aimed to combat antimicrobial resistance by developing a comprehensive, digitally-driven platform for viral therapy design. Their vision was to create a system capable of rapidly generating and deploying targeted viral solutions to address the growing crisis of antibiotic-resistant infections. This end-to-end platform sought to revolutionize how we approach and manage infectious diseases in a world where traditional antibiotics are becoming increasingly ineffective. However, the company is now inactive.